Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

FDA grants 510(k) clearance to the CorPath System for radial access PCI

The FDA granted a 510(k) clearance on Oct. 6 to the CorPath System for use during PCIs performed via radial access.

Thumbnail

TCT.15: Bioresorbable scaffold sessions highlight late-breaking clinical trials

For the past few years, the Transcatheter Cardiovascular Therapeutic (TCT) conference has focused on structural heart disease as a major subspecialty in interventional cardiology. This year’s conference, which runs from Oct. 10 to 15 in San Francisco, will have more of an emphasis on coronary intervention, according to TCT co-director Gregg W. Stone, MD.

Thumbnail

FDA approves first bioabsorbable polymer drug-eluting stent system

The FDA approved the Synergy bioabsorbable polymer drug-eluting stent system on Oct. 5 to treat coronary artery disease. The Synergy stent is the first FDA-approved bioabsorbable polymer drug-eluting stent system, according to Boston Scientific, its manufacturer. The stent was approved in Europe in 2012.

Thumbnail

Getting Back to Basics for Complex Patients

Problems put off are problems exacerbated. In life and health, we need to study and address problems to find solutions. 

Thumbnail

PCI Gets Personal: How to Avoid Bleeds

PCI-related bleeding events potentially carry a host of unwanted consequences.

Thumbnail

Advanced Analytics Make Supply Chain Pros of Cath Lab Teams

Cardinal Health

Good Samaritan Hospital in L.A. looks to its managers to preserve that margin by slashing supply costs without compromising clinical quality.

Thumbnail

[ARTICLE] Building a Protected PCI Program: The Heart Team Approach

Offered in cooperation with Abiomed

High-risk PCI patients have new options at Einstein Healthcare Network in Philadelphia with the Impella 2.5, a miniature heart pump for use in elective and urgent high-risk PCI procedures.

FDA issues Class I recall of Syncardia Freedom driver

The FDA has issued a Class I recall of a select number of SynCardia Systems Total Artificial Heart Freedom driver.

Displaying 1497 - 1504 of 2707

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.